Fariba Vaziri‐Sani

Loss-of-function mutations in SLC30A8 protect against type 2 diabetes

Jason Flannick, Nicola L. Beer, Suzanne B.R. Jacobs et al. · Nature Genetics · 2014 · 497 citations

Medicine, Genetics, Molecular Genetics +13

Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation

Anne-lie Ståhl, Fariba Vaziri‐Sani, Stefan Heinen et al. · Blood · 2008 · 138 citations · Full text

Medicine, Hematology, Immunology +14

ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset

Fariba Vaziri‐Sani, Shilpa Oak, Jared Radtke et al. · Autoimmunity · 2010 · 88 citations

Life Sciences, Endocrinology, Immunology +11

Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome

Fariba Vaziri‐Sani, Lars Holmberg, Anders G. Sjöholm et al. · Kidney International · 2006 · 88 citations

Medicine, Genetics, Molecular Genetics +11

The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes

Cecilia Andersson, K. Larsson, Fariba Vaziri‐Sani et al. · Autoimmunity · 2011 · 86 citations · Full text

Life Sciences, Endocrinology, Pediatrics +17